The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PLX FINANCIAL STATEMENTS

Protalix Biotherapeutics Inc — balance sheet, income statement and cash flow trends

PLXProtalix Biotherapeutics Inc

🇺🇸 USA · AMEX · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
050 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue80.6 M $Gross Profit55.8 M $ · 69%Operating Income23.3 M $ · 29%Pre-tax Income23.5 M $ · 29%Net Income to Owners18.9 M $ · 23%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue80.6 M $+30.1%
Gross Profit55.8 M $+56.5%
Operating Income23.3 M $+183.1%
EBITDA26.3 M $+149.1%
Net Income to Owners18.9 M $+201.9%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 M100 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets110.3 M
  • Equity71.4 M $65%
  • Current Liabilities31.4 M $28%
  • Long-term Liabilities7.5 M $7%

Key Figures

YoY change
Total Assets110.3 M $+40.6%
Total Liabilities38.9 M $+36.2%
Total Equity71.4 M $+43.1%
Cash & ST Investments40.7 M $+21.7%
Total Debt9.2 M $+72.1%
Net Debt-18.2 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-20 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
010 M9.9 M $Operating-1 M $Investing9.5 M $Financing18.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow9.9 M $—
Capital Expenditures2.3 M $+80.5%
Free Cash Flow7.7 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PLX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.